FEATURE
Creating a Thriving Innovation Economy in Washington
October 1, 2009 | Xconomy
What can state or local government do to spur an innovation economy? The single biggest correlate to the strength of an innovative biotechnology industry in any geography is the quality of the major research institutions. Carl Weissman Chairman and CEO of Seattle's Accelerator and Managing Director at OVP Venture Partners offers additonal suggestions.
Read More
Venture-Backed Exit Market Continues to Face Challenges
October 1, 2009 | NVCA/peHUB
Venture-backed company exit activity showed little signs of life during the third quarter of 2009 and fell far short of historical norms, according to the Exit Poll report by Thomson Reuters and the National Venture Capital Association (NVCA).
Read More
Painful Lesson on Patents
October 2, 2009 | Inside Higher Ed
The U.S. Court of Appeals told a lower court judge to dismiss a lawsuit Stanford had brought accusing the pharmaceutical company Roche of infringing its patent on a technology that measures the concentration of HIV in blood plasma. Stanford lost the case, essentially, because its policy on who owns inventions created using university resources required researchers to "agree to assign" ownership rights to the university
Read More
The Depressing Reality Of Venture Capital
October 1, 2009 | Business Insider
M&A exits for venture-backed companies totaled $2.9 billion during the third quarter, down 49% from a year ago, according to Venture Source. That's particularly sad because you might recall that last year wasn't a very good year for the economy.
Read More
|
|
MoreLIP: Badgers Attract Biotech Gophers
George Lipper, Editor
Thomas Lee of the Minneapolis Star Tribune writes a two-part series on Wisconsin's biotechnology investment prowess, bounding ahead of Minnesota with a broad, tax-friendly strategy.
Read More
|